What changed
Revenue fell NZD$689m (-9%) to NZD$7.0bn, reflecting broad-based volume declines across New Zealand operations in particular. The operating loss swung from a NZD$176m profit to a NZD$260m loss — a NZD$436m deterioration — as lower volumes collided with persistent cost inflation and what management describes as intense competitive pressure. PBT deepened to a NZD$432m loss from NZD$24m in FY24, the cleaner read given distorted tax lines in both years.
The NPAT of -NZD$419m versus -NZD$227m in FY24 is noisier than PBT suggests, for two reasons: FY25 carries a NZD$52m discontinued-operation loss (smaller than FY24's NZD$141m drag) and a NZD$67m tax benefit on the pre-tax loss, implying an effective tax rate of -15.5% against FY24's anomalous 229% rate. The discontinued-operation shrinkage, not an underlying improvement, explains a large portion of the NPAT movement appearing less severe than the PBT trajectory implies.
On the balance sheet, the story is materially different. Gross borrowings fell NZD$936m (-44%) to NZD$1.17bn — driven by a capital raise that repaid NZD$511m of bank debt and A$160m of asset sale proceeds — reducing implied net debt to approximately NZD$1.0bn from NZD$1.8bn. Capex dropped to NZD$280m from NZD$429m. Operating cash flow improved to NZD$501m from NZD$398m, almost entirely generated in H2 (NZD$506m versus NZD$-5m in H1).
What matters
The divergence between cash generation and reported earnings is stark, and its durability is the central question. Free cash excluding Significant Items rose to NZD$333m from NZD$304m even as the statutory loss widened. The H2 operating cash flow of NZD$506m is the mechanical product of capex restraint, working capital timing, and significant-item accounting — not a recovery in underlying trading margins. Inventory days expanded to 99.5 from 88.8, suggesting working capital relief in H2 may have borrowed from a payables cycle rather than reflecting genuine earnings improvement.
Leverage reduction is real but the endpoint is still distant. Management has set a threshold condition — net debt must reach the lower half of NZD$400m–$900m before dividends resume. At NZD$1.0bn, the Group sits above the entire target range, let alone its lower half. With no quantitative earnings guidance provided and New Zealand construction markets still under pressure, the path to that threshold is not clearly mapped. The capital raise and asset disposal proceeds have done the heavy lifting so far; what drives the next leg of deleveraging is not specified.
The H2 loss acceleration warrants scrutiny. NPAT loss of NZD$285m in H2 against NZD$134m in H1 means conditions worsened through the year rather than stabilised, which complicates the implicit narrative that cost reductions weighted to H2 would improve results.
Expectations
No quantitative FY26 guidance was provided. The filing contains no forward order book or pipeline disclosure to anchor expectations. Without those inputs, the result can only be assessed against internal indicators and the stated balance-sheet target.
Against that limited context:
- The revenue decline of 9% is consistent with the HY25 signal of broad-based volume softness, but the H2 operating deterioration — despite promised cost-out weighting to the second half — suggests the cost programme did not offset volume losses at the margin level.
- The H1 flagged gross cost reductions of NZD$91m with more weighted to H2; the statutory result does not obviously reflect a step-change in underlying profitability in that half.
- The NZD$1.0bn net debt position means the dividend resumption condition will not be met in the near term unless asset disposals, debt repayment, or a sharp earnings recovery materialise in FY26.
- Operating cash flow of NZD$501m is encouraging in absolute terms but is heavily H2-weighted and partly capex-suppression driven; sustaining that level with a stabilised capex programme and still-soft volumes is not a given.
Quality of result
The FY25 result has limited durable quality at the earnings line. The operating loss reflects genuine structural deterioration — volume declines, compressed margins, and fixed cost absorption — rather than one-off charges that will cleanly reverse. The NZD$52m discontinued-operation loss, while smaller than FY24's NZD$141m, remains a real cash and P&L drag. The tax benefit distorts NPAT upward relative to economic performance.
Cash generation quality is mixed. The NZD$333m free cash excluding Significant Items figure benefits from two non-recurring tailwinds: capex reduced by NZD$149m year-on-year (a 35% cut that cannot be sustained indefinitely without affecting asset quality) and H2 working capital release that appears partly inventory-timing related given the inventory day build. The equity increase to NZD$3.6bn reflects the capital raise rather than retained earnings, which is balance-sheet-assisted rather than operationally earned.
On balance, the deleveraging is the most durable development this period. The earnings improvement path is not yet visible in the operating numbers.
Unresolved
- What is the current-period segment revenue and margin breakdown? The extraction contains only FY24 segment data; without FY25 comparatives, it is impossible to identify which divisions are driving the margin collapse and which are holding.
- How much of the H2 free cash flow reflects genuine operating improvement versus deferred payables or one-time working capital timing that will reverse in H1 FY26?
- What is the composition and pace of the cost-out programme beyond the NZD$91m disclosed at H1, and at what revenue level does it return the Group to breakeven?
- The NZD$1.0bn net debt figure sits above the entire NZD$400m–$900m target range; what specific asset disposals, earnings recovery, or further capital actions are contemplated to close that gap?
- Inventory days expanded almost 11 days year-on-year against falling revenue — the risk of inventory write-downs or further margin pressure from destocking has not been addressed.
This briefing cannot assess whether the H2 cost reductions represent a genuine structural reset or a timing shift that will reassert as volume and margin pressure in FY26.
Key metrics
| Metric | FY25 | FY24 | Change |
|---|---|---|---|
| Revenue | $6994m | $7683m | -9.0% ↓ |
| Net profit after tax | −$419m | −$227m | -84.6% ↓ |
| Net cash inflow from operating activities | $501m | $398m | +25.9% ↑ |
| Operating profit | −$260m | $176m | -247.7% ↓ |
| Profit before tax | −$432m | −$24m | -1700.0% ↓ |
| Cash and cash equivalents | $139m | $311m | -55.3% ↓ |
| Total assets | $7898m | $8874m | -11.0% ↓ |
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Building Products | — | $1345m | — | n/a |
| Distribution | — | $1615m | — | n/a |
| Concrete | — | $1082m | — | n/a |
| Australia | — | $1979m | — | n/a |
| Residential and Development | — | $796m | — | n/a |
| Construction | — | $1614m | — | n/a |
| Other | — | $10m | — | n/a |
Analytical metrics
| Metric | FY25 | FY24 | Context |
|---|---|---|---|
| FCF pre-lease | $333.0m | $304.0m | +$29.0m |
| FCF / NPAT | -79.5% | -133.9% | complementary conversion metric |
| Capex % revenue | 4.0% | 5.6% | — |
| Capex | −$280.0m | $429.0m | −$709.0m |
| Free cash flow | $333.0m | $304.0m | +$29.0m |
| Debtor days | 32.3 | 30.2 | +2.1 days |
| Inventory days | 99.5 | 88.8 | +10.7 days |
| Trade debtors | $618.0m | $636.0m | −$18.0m |
| Net debt | $1033.0m | $1797.0m | −$764.0m |
| Gross borrowings | $1172.0m | $2108.0m | −$936.0m |
| Payout ratio vs FCF pre-lease | 0.0% | — | covered |
| ROE (annualised) | -11.6% | -6.8% | Weakening |
| HY25 share of FY25 revenue | 51.2% | — | Other half was 48.8% |
| HY25 share of FY25 NPAT | 32.0% | — | Other half was 68.0% |
| Profit from continuing operations | −$365.0m | −$79.0m | −$286.0m |
| Discontinued operation after tax | −$52.0m | −$141.0m | +$89.0m |
This analysis was generated using Annolyse, an AI-powered tool that extracts and analyses NZX/ASX company announcements. The underlying data is extracted from official company filings and verified against source documents. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.